Basis of Presentation, Organization and Business and Summary of Significant Accounting Policies (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 22, 2017
USD ($)
Oct. 19, 2017
USD ($)
Number
May 10, 2010
USD ($)
Dec. 31, 2016
shares
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Jun. 30, 2018
USD ($)
Segment
shares
Jun. 30, 2017
USD ($)
shares
Jun. 30, 2016
USD ($)
shares
Ownership percentage         100.00%               100.00%    
Number of operating segment | Segment                         1    
Cash and cash equivalents         $ 10,979,455               $ 10,979,455    
Cash held uninsured amount         10,729,455               10,729,455    
Sales from continuing operations $ 8,323,845       8,636,126 $ 12,439,132   $ 7,280,723 $ 7,890,195 $ 7,177,763 $ 6,030,380 $ 6,171,625 36,679,826 $ 27,269,963 $ 23,113,194
Accounts receivable         293,915               293,915    
Finite lived intangible assets, net         757,447       719,136       $ 757,447 $ 719,136  
Excluded from the calculation of diluted EPS | shares                         211,801 473,848 467,733
Advertising expense                         $ 0 $ 76,000 $ 386,000
Shipping and handling fees $ 2,465,826       2,519,824 2,631,893   2,177,355 2,374,661 $ 2,112,099 $ 1,818,672 $ 1,912,007 9,794,898 8,217,439 7,640,626
Deferred income taxes                         908,875    
Payments of manufacturing and distribution rights                         165,388 224,394 $ 132,731
Restricted Stock [Member]                              
Excluded from the calculation of diluted EPS | shares       400,000                      
Generators [Member]                              
Estimated useful lives                             P3Y
Depreciation expense                         $ 487,000 425,000 $ 416,000
Impact of change in accounting estimate reduction in expenses                           283,000  
Distribution Rights [Member]                              
Payments of manufacturing and distribution rights   $ 11,000,000                          
Amount of upfront fees and stocking orders   5,000,000                          
Monthly installments of upfront fees and stocking orders   $ 1,000,000                          
Number of monthly installments | Number   5                          
Minimum royalty payments in 2019   $ 2,000,000                          
Minimum royalty payments in 2020   2,000,000                          
Minimum royalty payments in 2021   2,000,000                          
Reimbursement of technology transfer costs   $ 1,000,000                          
Patents [Member]                              
Intangible assets estimated useful lives                         17 years    
Finite lived intangible assets, net         757,447       719,136       $ 757,447 719,136  
Amortization expense                         $ 127,000 110,000 94,000
BoneScapel Generators [Member]                              
Estimated useful lives                         P5Y    
Sonic OneOR Generators [Member]                              
Estimated useful lives                         P5Y    
Shipping and Handling [Member] | Net Sales [Member]                              
Shipping and handling fees                         $ 99,000 119,000 109,000
Shipping and Handling [Member] | Selling Expenses [Member]                              
Shipping and handling fees                         289,000 337,000 142,000
Royalty [Member]                              
Royalty fee                         $ 2,000,000    
Term of the Agreement                         10 years    
License [Member]                              
Sales from continuing operations         4,010,000         $ 4,010,000
Minimum [Member]                              
Estimated useful lives                         P3Y    
Maximum [Member]                              
Estimated useful lives                         P5Y    
International [Member]                              
Sales from continuing operations                         $ 16,635,463 10,809,192 10,026,388
Accounts receivable         1,630,000       860,000       1,630,000 860,000  
SonaCare Medical ("SonaCare") [Member]                              
Proceeds from sale of intangible assets     $ 5,800,000                   2,542,579    
Earn-out percentage     7.00%                        
Proceeds from sale of intangible assets     $ 3,000,000                        
Earn-out percentage     5.00%                        
Proceeds from sale of intangible assets     $ 5,800,000                        
Annual Royalty     $ 250,000                        
SonaStar Surgical Aspirator (SonaStar) [Member]                              
Sales from continuing operations                         6,969,258 0 0
Medtronic Minimally Invasive Therapies ("MMIT) [Member]                              
Accounts receivable         $ 0       $ 925,000       0 $ 925,000  
Medtronic Minimally Invasive Therapies ("MMIT) [Member] | License Agreement [Member]                              
Agreement expiration date                           2017-08  
Medtronic Minimally Invasive Therapies ("MMIT) [Member] | Royalty [Member] | License Agreement [Member]                              
Sales from continuing operations                         525,000 $ 3,764,000 $ 3,903,000
SonaStar productSonaStar) [Member]                              
Sales from continuing operations           $ 150,000 $ 570,000 $ 270,000         $ 990,000